Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

November 01, 2019; Volume 371,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Adham, Nika

    1. You have access
      The Role of Dopamine D3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens
      Mei Huang, Wenqi He, Béla Kiss, Bence Farkas, Nika Adham and Herbert Y. Meltzer
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 517-525; DOI: https://doi.org/10.1124/jpet.119.259879
  2. Ando, Ayumi

    1. You have access
      A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in ApoE Knockout Mice
      Shuichi Takagahara, Hiromi Shinohara, Shigekazu Itokawa, Yoshinori Satomi, Ayumi Ando, Takeshi Yamamoto, Hideo Suzuki, Takuya Fujimoto, Kazuki Kubo and Shota Ikeda
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 290-298; DOI: https://doi.org/10.1124/jpet.119.259846
  3. Andrews, Paul S.

    1. You have access
      Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat
      James T. Meyer, Brian A. Sparling, William J. McCarty, Maosheng Zhang, Marcus Soto, Stephen Schneider, Hao Chen, Jonathan Roberts, Helming Tan, Thomas Kornecook, Paul S. Andrews and Charles G. Knutson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 476-486; DOI: https://doi.org/10.1124/jpet.119.257105
  4. Arman, Tarana

    1. You have access
      A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model
      Michelle L. Montonye, Dan-Dan Tian, Tarana Arman, Katherine D. Lynch, Bruno Hagenbuch, Mary F. Paine and John D. Clarke
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 385-393; DOI: https://doi.org/10.1124/jpet.119.260489
  5. Aubé, Jeffrey

    1. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      You have access
      Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      Shane W. Kaski, Allison N. White, Joshua D. Gross, Kristen R. Trexler, Kim Wix, Aubrie A. Harland, Thomas E. Prisinzano, Jeffrey Aubé, Steven G. Kinsey, Terry Kenakin, David P. Siderovski and Vincent Setola
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 487-499; DOI: https://doi.org/10.1124/jpet.118.255661

B

  1. Balakrishna, Deepika

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  2. Banerjee, Urmi

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  3. Bardo, Michael T.

    1. You have access
      GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine
      Na-Ra Lee, Guangrong Zheng, Markos Leggas, Venumadhav Janganati, Justin R. Nickell, Peter A. Crooks, Michael T. Bardo and Linda P. Dwoskin
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 526-543; DOI: https://doi.org/10.1124/jpet.119.258699
  4. Barr, Jeffrey L.

    1. You have access
      Differential Roles of Accumbal GSK3β in Cocaine versus Morphine-Induced Place Preference, U50,488H-Induced Place Aversion, and Object Memory
      Xiangdang Shi, Jeffrey L. Barr, Eva von Weltin, Cassandra Wolsh and Ellen M. Unterwald
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 339-347; DOI: https://doi.org/10.1124/jpet.119.259283
  5. Bartkowski, Darian

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  6. Beebe, Jenny

    1. You have access
      CC-115, a Dual Mammalian Target of Rapamycin/DNA-Dependent Protein Kinase Inhibitor in Clinical Trial, Is a Substrate of ATP-Binding Cassette G2, a Risk Factor for CC-115 Resistance
      Jenny Beebe and Jian-Ting Zhang
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 320-326; DOI: https://doi.org/10.1124/jpet.119.258392
  7. Bergeria, Cecilia L.

    1. You have access
      Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence
      Kelly E. Dunn, Andrew S. Huhn, Cecilia L. Bergeria, Cassandra D. Gipson and Elise M. Weerts
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 422-452; DOI: https://doi.org/10.1124/jpet.119.258004
  8. Bergman, Jack

    1. You have access
      Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment
      Sarah L. Withey, Roger D. Spealman, Jack Bergman and Carol A. Paronis
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 544-554; DOI: https://doi.org/10.1124/jpet.119.259010
  9. Bilakovics, James

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  10. Bobardt, Michael

    1. Open Access
      A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
      Joseph Kuo, Michael Bobardt, Udayan Chatterji, Patrick R. Mayo, Daniel J. Trepanier, Robert T. Foster, Philippe Gallay and Daren R. Ure
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 231-241; DOI: https://doi.org/10.1124/jpet.119.261099
  11. Bowman, Melodi A.

    1. Open Access
      Age- and Sex-Specific Plasticity in Dopamine Transporter Function Revealed by Food Restriction and Exercise in a Rat Activity-Based Anorexia Paradigm
      T. Lee Gilman, W. Anthony Owens, Christina M. George, Lauren Metzel, Melissa Vitela, Livia Ferreira, Melodi A. Bowman, Georgianna G. Gould, Glenn M. Toney and Lynette C. Daws
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 268-277; DOI: https://doi.org/10.1124/jpet.119.260794
  12. Broens, Suzanne

    1. You have access
      A Pragmatic Utility Function to Describe the Risk-Benefit Composite of Opioid and Nonopioid Analgesic Medication
      Anne E. Olesen, Suzanne Broens, Søren S. Olesen, Marieke Niesters, Monique van Velzen, Asbjørn M. Drewes, Albert Dahan and Erik Olofsen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 416-421; DOI: https://doi.org/10.1124/jpet.118.253716
  13. Bunce, Matthew

    1. You have access
      Pharmacological Profile of JNJ-64179375: A Novel, Long-Acting Exosite-1 Thrombin Inhibitor
      Zheng Huang Devine, Fuyong Du, Qiu Li, Matthew Bunce, Eilyn R. Lacy and Madhu Chintala
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 375-384; DOI: https://doi.org/10.1124/jpet.119.261032

C

  1. Cai, Zhulan

    1. You have access
      Indigo Fruits Ingredient, Aucubin, Protects against LPS-Induced Cardiac Dysfunction in Mice
      MingXia Duan, Yuan Yuan, Chen Liu, Zhulan Cai, Qingwen Xie, Tongtong Hu, Qizhu Tang and QingQing Wu
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 348-359; DOI: https://doi.org/10.1124/jpet.119.259069
  2. Carpéné, Christian

    1. You have access
      Oral Phenelzine Treatment Mitigates Metabolic Disturbances in Mice Fed a High-Fat Diet
      Josep Mercader, Agustín G. Sabater, Sophie Le Gonidec, Pauline Decaunes, Alice Chaplin, Saioa Gómez-Zorita, Fermín I. Milagro and Christian Carpéné
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 555-566; DOI: https://doi.org/10.1124/jpet.119.259895
  3. Chaplin, Alice

    1. You have access
      Oral Phenelzine Treatment Mitigates Metabolic Disturbances in Mice Fed a High-Fat Diet
      Josep Mercader, Agustín G. Sabater, Sophie Le Gonidec, Pauline Decaunes, Alice Chaplin, Saioa Gómez-Zorita, Fermín I. Milagro and Christian Carpéné
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 555-566; DOI: https://doi.org/10.1124/jpet.119.259895
  4. Chatterji, Udayan

    1. Open Access
      A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
      Joseph Kuo, Michael Bobardt, Udayan Chatterji, Patrick R. Mayo, Daniel J. Trepanier, Robert T. Foster, Philippe Gallay and Daren R. Ure
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 231-241; DOI: https://doi.org/10.1124/jpet.119.261099
  5. Chen, Hao

    1. You have access
      Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat
      James T. Meyer, Brian A. Sparling, William J. McCarty, Maosheng Zhang, Marcus Soto, Stephen Schneider, Hao Chen, Jonathan Roberts, Helming Tan, Thomas Kornecook, Paul S. Andrews and Charles G. Knutson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 476-486; DOI: https://doi.org/10.1124/jpet.119.257105
  6. Chen, Hong

    1. You have access
      Streptozotocin-Induced Diabetic Neuropathic Pain Is Associated with Potentiated Calcium-Permeable AMPA Receptor Activity in the Spinal Cord
      Shao-Rui Chen, Jixiang Zhang, Hong Chen and Hui-Lin Pan
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 242-249; DOI: https://doi.org/10.1124/jpet.119.261339
  7. Chen, Shao-Rui

    1. You have access
      Streptozotocin-Induced Diabetic Neuropathic Pain Is Associated with Potentiated Calcium-Permeable AMPA Receptor Activity in the Spinal Cord
      Shao-Rui Chen, Jixiang Zhang, Hong Chen and Hui-Lin Pan
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 242-249; DOI: https://doi.org/10.1124/jpet.119.261339
  8. Chern, Yijuang

    1. You have access
      Novel Adenosine Analog, N6-(4-Hydroxybenzyl)-Adenosine, Dampens Alcohol Drinking and Seeking Behaviors
      Sa-Ik Hong, Lee Peyton, Yijuang Chern and Doo-Sup Choi
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 260-267; DOI: https://doi.org/10.1124/jpet.119.261529
  9. Cheruvallath, Zacharia S.

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  10. Chhonker, Yashpal S.

    1. You have access
      In Vivo Evaluation of Isoprenoid Triazole Bisphosphonate Inhibitors of Geranylgeranyl Diphosphate Synthase: Impact of Olefin Stereochemistry on Toxicity and Biodistribution
      Staci L. Haney, Yashpal S. Chhonker, Michelle L. Varney, Geoffrey Talmon, Lynette M. Smith, Daryl J. Murry and Sarah A. Holstein
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 327-338; DOI: https://doi.org/10.1124/jpet.119.258624
  11. Chintala, Madhu

    1. You have access
      Pharmacological Profile of JNJ-64179375: A Novel, Long-Acting Exosite-1 Thrombin Inhibitor
      Zheng Huang Devine, Fuyong Du, Qiu Li, Matthew Bunce, Eilyn R. Lacy and Madhu Chintala
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 375-384; DOI: https://doi.org/10.1124/jpet.119.261032
  12. Choi, Doo-Sup

    1. You have access
      Novel Adenosine Analog, N6-(4-Hydroxybenzyl)-Adenosine, Dampens Alcohol Drinking and Seeking Behaviors
      Sa-Ik Hong, Lee Peyton, Yijuang Chern and Doo-Sup Choi
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 260-267; DOI: https://doi.org/10.1124/jpet.119.261529
  13. Clarke, John D.

    1. You have access
      A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model
      Michelle L. Montonye, Dan-Dan Tian, Tarana Arman, Katherine D. Lynch, Bruno Hagenbuch, Mary F. Paine and John D. Clarke
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 385-393; DOI: https://doi.org/10.1124/jpet.119.260489
  14. Cote, Thomas E.

    1. You have access
      Addressing the Opioid Crisis: Medical Student Instruction in Opioid Drug Pharmacology, Pain Management, and Substance Use Disorders
      Brian M. Cox, Thomas E. Cote and Irwin Lucki
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 500-506; DOI: https://doi.org/10.1124/jpet.119.257329
  15. Coussens, Nathan P.

    1. You have access
      The Opioid Crisis and the Future of Addiction and Pain Therapeutics
      Nathan P. Coussens, G. Sitta Sittampalam, Samantha G. Jonson, Matthew D. Hall, Heather E. Gorby, Amir P. Tamiz, Owen B. McManus, Christian C. Felder and Kurt Rasmussen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 396-408; DOI: https://doi.org/10.1124/jpet.119.259408
  16. Cox, Brian M.

    1. You have access
      Addressing the Opioid Crisis: Medical Student Instruction in Opioid Drug Pharmacology, Pain Management, and Substance Use Disorders
      Brian M. Cox, Thomas E. Cote and Irwin Lucki
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 500-506; DOI: https://doi.org/10.1124/jpet.119.257329
  17. Crooks, Peter A.

    1. You have access
      GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine
      Na-Ra Lee, Guangrong Zheng, Markos Leggas, Venumadhav Janganati, Justin R. Nickell, Peter A. Crooks, Michael T. Bardo and Linda P. Dwoskin
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 526-543; DOI: https://doi.org/10.1124/jpet.119.258699
  18. Crystal, Roger

    1. You have access
      Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose
      Philip Krieter, Shwe Gyaw, Roger Crystal and Phil Skolnick
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 409-415; DOI: https://doi.org/10.1124/jpet.118.256115
  19. Cui, Su-Ying

    1. Open Access
      Protection from Amyloid β Peptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor
      Su-Ying Cui, Ming-Xin Yang, Yong-He Zhang, Victor Zheng, Han-Ting Zhang, Mark E. Gurney, Ying Xu and James M. O’Donnell
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 250-259; DOI: https://doi.org/10.1124/jpet.119.259986
  20. Cunningham, Kathryn A.

    1. You have access
      Translating Pharmacology into Therapeutics to Fight the Opioid Crisis
      Gerard J. Marek, Kathryn A. Cunningham and Kurt Rasmussen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 394-395; DOI: https://doi.org/10.1124/jpet.119.262477

D

  1. Dahan, Albert

    1. You have access
      A Pragmatic Utility Function to Describe the Risk-Benefit Composite of Opioid and Nonopioid Analgesic Medication
      Anne E. Olesen, Suzanne Broens, Søren S. Olesen, Marieke Niesters, Monique van Velzen, Asbjørn M. Drewes, Albert Dahan and Erik Olofsen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 416-421; DOI: https://doi.org/10.1124/jpet.118.253716
  2. Daws, Lynette C.

    1. Open Access
      Age- and Sex-Specific Plasticity in Dopamine Transporter Function Revealed by Food Restriction and Exercise in a Rat Activity-Based Anorexia Paradigm
      T. Lee Gilman, W. Anthony Owens, Christina M. George, Lauren Metzel, Melissa Vitela, Livia Ferreira, Melodi A. Bowman, Georgianna G. Gould, Glenn M. Toney and Lynette C. Daws
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 268-277; DOI: https://doi.org/10.1124/jpet.119.260794
  3. Decaunes, Pauline

    1. You have access
      Oral Phenelzine Treatment Mitigates Metabolic Disturbances in Mice Fed a High-Fat Diet
      Josep Mercader, Agustín G. Sabater, Sophie Le Gonidec, Pauline Decaunes, Alice Chaplin, Saioa Gómez-Zorita, Fermín I. Milagro and Christian Carpéné
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 555-566; DOI: https://doi.org/10.1124/jpet.119.259895
  4. Dias, Henrique B.

    1. You have access
      Withaferin A Improves Nonalcoholic Steatohepatitis in Mice
      Daxesh P. Patel, Tingting Yan, Donghwan Kim, Henrique B. Dias, Kristopher W. Krausz, Shioko Kimura and Frank J. Gonzalez
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 360-374; DOI: https://doi.org/10.1124/jpet.119.256792
  5. Disney, Alex

    1. You have access
      Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats
      Lisa R. Gerak, Vanessa Minervini, Elizabeth Latham, Saba Ghodrati, Katherine V. Lillis, Jessica Wooden, Alex Disney, Stephen M. Husbands and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 507-516; DOI: https://doi.org/10.1124/jpet.119.260331
  6. Drewes, Asbjørn M.

    1. You have access
      A Pragmatic Utility Function to Describe the Risk-Benefit Composite of Opioid and Nonopioid Analgesic Medication
      Anne E. Olesen, Suzanne Broens, Søren S. Olesen, Marieke Niesters, Monique van Velzen, Asbjørn M. Drewes, Albert Dahan and Erik Olofsen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 416-421; DOI: https://doi.org/10.1124/jpet.118.253716
  7. Du, Fuyong

    1. You have access
      Pharmacological Profile of JNJ-64179375: A Novel, Long-Acting Exosite-1 Thrombin Inhibitor
      Zheng Huang Devine, Fuyong Du, Qiu Li, Matthew Bunce, Eilyn R. Lacy and Madhu Chintala
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 375-384; DOI: https://doi.org/10.1124/jpet.119.261032
  8. Duan, MingXia

    1. You have access
      Indigo Fruits Ingredient, Aucubin, Protects against LPS-Induced Cardiac Dysfunction in Mice
      MingXia Duan, Yuan Yuan, Chen Liu, Zhulan Cai, Qingwen Xie, Tongtong Hu, Qizhu Tang and QingQing Wu
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 348-359; DOI: https://doi.org/10.1124/jpet.119.259069
  9. Dunn, Kelly E.

    1. You have access
      Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence
      Kelly E. Dunn, Andrew S. Huhn, Cecilia L. Bergeria, Cassandra D. Gipson and Elise M. Weerts
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 422-452; DOI: https://doi.org/10.1124/jpet.119.258004
  10. Dwoskin, Linda P.

    1. You have access
      GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine
      Na-Ra Lee, Guangrong Zheng, Markos Leggas, Venumadhav Janganati, Justin R. Nickell, Peter A. Crooks, Michael T. Bardo and Linda P. Dwoskin
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 526-543; DOI: https://doi.org/10.1124/jpet.119.258699

E

  1. Ermolieff, Jacques

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028

F

  1. Fanjul, Andrea

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  2. Farkas, Bence

    1. You have access
      The Role of Dopamine D3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens
      Mei Huang, Wenqi He, Béla Kiss, Bence Farkas, Nika Adham and Herbert Y. Meltzer
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 517-525; DOI: https://doi.org/10.1124/jpet.119.259879
  3. Farrell, Pamela J.

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  4. Felder, Christian C.

    1. You have access
      The Opioid Crisis and the Future of Addiction and Pain Therapeutics
      Nathan P. Coussens, G. Sitta Sittampalam, Samantha G. Jonson, Matthew D. Hall, Heather E. Gorby, Amir P. Tamiz, Owen B. McManus, Christian C. Felder and Kurt Rasmussen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 396-408; DOI: https://doi.org/10.1124/jpet.119.259408
  5. Ferreira, Livia

    1. Open Access
      Age- and Sex-Specific Plasticity in Dopamine Transporter Function Revealed by Food Restriction and Exercise in a Rat Activity-Based Anorexia Paradigm
      T. Lee Gilman, W. Anthony Owens, Christina M. George, Lauren Metzel, Melissa Vitela, Livia Ferreira, Melodi A. Bowman, Georgianna G. Gould, Glenn M. Toney and Lynette C. Daws
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 268-277; DOI: https://doi.org/10.1124/jpet.119.260794
  6. Fletcher, Terry W.

    1. You have access
      Doxorubicin Activates Ryanodine Receptors in Rat Lymphatic Muscle Cells to Attenuate Rhythmic Contractions and Lymph Flow
      Amanda J. Stolarz, Mustafa Sarimollaoglu, John C. Marecki, Terry W. Fletcher, Ekaterina I. Galanzha, Sung W. Rhee, Vladimir P. Zharov, V. Suzanne Klimberg and Nancy J. Rusch
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 278-289; DOI: https://doi.org/10.1124/jpet.119.257592
  7. Foster, Robert T.

    1. Open Access
      A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
      Joseph Kuo, Michael Bobardt, Udayan Chatterji, Patrick R. Mayo, Daniel J. Trepanier, Robert T. Foster, Philippe Gallay and Daren R. Ure
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 231-241; DOI: https://doi.org/10.1124/jpet.119.261099
  8. France, Charles P.

    1. You have access
      Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats
      Lisa R. Gerak, Vanessa Minervini, Elizabeth Latham, Saba Ghodrati, Katherine V. Lillis, Jessica Wooden, Alex Disney, Stephen M. Husbands and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 507-516; DOI: https://doi.org/10.1124/jpet.119.260331
  9. Fujimoto, Takuya

    1. You have access
      A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in ApoE Knockout Mice
      Shuichi Takagahara, Hiromi Shinohara, Shigekazu Itokawa, Yoshinori Satomi, Ayumi Ando, Takeshi Yamamoto, Hideo Suzuki, Takuya Fujimoto, Kazuki Kubo and Shota Ikeda
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 290-298; DOI: https://doi.org/10.1124/jpet.119.259846

G

  1. Galanzha, Ekaterina I.

    1. You have access
      Doxorubicin Activates Ryanodine Receptors in Rat Lymphatic Muscle Cells to Attenuate Rhythmic Contractions and Lymph Flow
      Amanda J. Stolarz, Mustafa Sarimollaoglu, John C. Marecki, Terry W. Fletcher, Ekaterina I. Galanzha, Sung W. Rhee, Vladimir P. Zharov, V. Suzanne Klimberg and Nancy J. Rusch
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 278-289; DOI: https://doi.org/10.1124/jpet.119.257592
  2. Gallay, Philippe

    1. Open Access
      A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
      Joseph Kuo, Michael Bobardt, Udayan Chatterji, Patrick R. Mayo, Daniel J. Trepanier, Robert T. Foster, Philippe Gallay and Daren R. Ure
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 231-241; DOI: https://doi.org/10.1124/jpet.119.261099
  3. George, Christina M.

    1. Open Access
      Age- and Sex-Specific Plasticity in Dopamine Transporter Function Revealed by Food Restriction and Exercise in a Rat Activity-Based Anorexia Paradigm
      T. Lee Gilman, W. Anthony Owens, Christina M. George, Lauren Metzel, Melissa Vitela, Livia Ferreira, Melodi A. Bowman, Georgianna G. Gould, Glenn M. Toney and Lynette C. Daws
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 268-277; DOI: https://doi.org/10.1124/jpet.119.260794
  4. Gerak, Lisa R.

    1. You have access
      Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats
      Lisa R. Gerak, Vanessa Minervini, Elizabeth Latham, Saba Ghodrati, Katherine V. Lillis, Jessica Wooden, Alex Disney, Stephen M. Husbands and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 507-516; DOI: https://doi.org/10.1124/jpet.119.260331
  5. Ghodrati, Saba

    1. You have access
      Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats
      Lisa R. Gerak, Vanessa Minervini, Elizabeth Latham, Saba Ghodrati, Katherine V. Lillis, Jessica Wooden, Alex Disney, Stephen M. Husbands and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 507-516; DOI: https://doi.org/10.1124/jpet.119.260331
  6. Gilman, T. Lee

    1. Open Access
      Age- and Sex-Specific Plasticity in Dopamine Transporter Function Revealed by Food Restriction and Exercise in a Rat Activity-Based Anorexia Paradigm
      T. Lee Gilman, W. Anthony Owens, Christina M. George, Lauren Metzel, Melissa Vitela, Livia Ferreira, Melodi A. Bowman, Georgianna G. Gould, Glenn M. Toney and Lynette C. Daws
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 268-277; DOI: https://doi.org/10.1124/jpet.119.260794
  7. Gipson, Cassandra D.

    1. You have access
      Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence
      Kelly E. Dunn, Andrew S. Huhn, Cecilia L. Bergeria, Cassandra D. Gipson and Elise M. Weerts
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 422-452; DOI: https://doi.org/10.1124/jpet.119.258004
  8. Gómez-Zorita, Saioa

    1. You have access
      Oral Phenelzine Treatment Mitigates Metabolic Disturbances in Mice Fed a High-Fat Diet
      Josep Mercader, Agustín G. Sabater, Sophie Le Gonidec, Pauline Decaunes, Alice Chaplin, Saioa Gómez-Zorita, Fermín I. Milagro and Christian Carpéné
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 555-566; DOI: https://doi.org/10.1124/jpet.119.259895
  9. Gonzalez, Frank J.

    1. You have access
      Withaferin A Improves Nonalcoholic Steatohepatitis in Mice
      Daxesh P. Patel, Tingting Yan, Donghwan Kim, Henrique B. Dias, Kristopher W. Krausz, Shioko Kimura and Frank J. Gonzalez
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 360-374; DOI: https://doi.org/10.1124/jpet.119.256792
  10. Gorby, Heather E.

    1. You have access
      The Opioid Crisis and the Future of Addiction and Pain Therapeutics
      Nathan P. Coussens, G. Sitta Sittampalam, Samantha G. Jonson, Matthew D. Hall, Heather E. Gorby, Amir P. Tamiz, Owen B. McManus, Christian C. Felder and Kurt Rasmussen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 396-408; DOI: https://doi.org/10.1124/jpet.119.259408
  11. Gould, Georgianna G.

    1. Open Access
      Age- and Sex-Specific Plasticity in Dopamine Transporter Function Revealed by Food Restriction and Exercise in a Rat Activity-Based Anorexia Paradigm
      T. Lee Gilman, W. Anthony Owens, Christina M. George, Lauren Metzel, Melissa Vitela, Livia Ferreira, Melodi A. Bowman, Georgianna G. Gould, Glenn M. Toney and Lynette C. Daws
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 268-277; DOI: https://doi.org/10.1124/jpet.119.260794
  12. Gross, Joshua D.

    1. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      You have access
      Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      Shane W. Kaski, Allison N. White, Joshua D. Gross, Kristen R. Trexler, Kim Wix, Aubrie A. Harland, Thomas E. Prisinzano, Jeffrey Aubé, Steven G. Kinsey, Terry Kenakin, David P. Siderovski and Vincent Setola
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 487-499; DOI: https://doi.org/10.1124/jpet.118.255661
  13. Gurney, Mark E.

    1. Open Access
      Protection from Amyloid β Peptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor
      Su-Ying Cui, Ming-Xin Yang, Yong-He Zhang, Victor Zheng, Han-Ting Zhang, Mark E. Gurney, Ying Xu and James M. O’Donnell
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 250-259; DOI: https://doi.org/10.1124/jpet.119.259986
  14. Gyaw, Shwe

    1. You have access
      Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose
      Philip Krieter, Shwe Gyaw, Roger Crystal and Phil Skolnick
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 409-415; DOI: https://doi.org/10.1124/jpet.118.256115

H

  1. Hagenbuch, Bruno

    1. You have access
      A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model
      Michelle L. Montonye, Dan-Dan Tian, Tarana Arman, Katherine D. Lynch, Bruno Hagenbuch, Mary F. Paine and John D. Clarke
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 385-393; DOI: https://doi.org/10.1124/jpet.119.260489
  2. Hall, Matthew D.

    1. You have access
      The Opioid Crisis and the Future of Addiction and Pain Therapeutics
      Nathan P. Coussens, G. Sitta Sittampalam, Samantha G. Jonson, Matthew D. Hall, Heather E. Gorby, Amir P. Tamiz, Owen B. McManus, Christian C. Felder and Kurt Rasmussen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 396-408; DOI: https://doi.org/10.1124/jpet.119.259408
  3. Haney, Staci L.

    1. You have access
      In Vivo Evaluation of Isoprenoid Triazole Bisphosphonate Inhibitors of Geranylgeranyl Diphosphate Synthase: Impact of Olefin Stereochemistry on Toxicity and Biodistribution
      Staci L. Haney, Yashpal S. Chhonker, Michelle L. Varney, Geoffrey Talmon, Lynette M. Smith, Daryl J. Murry and Sarah A. Holstein
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 327-338; DOI: https://doi.org/10.1124/jpet.119.258624
  4. Harland, Aubrie A.

    1. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      You have access
      Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      Shane W. Kaski, Allison N. White, Joshua D. Gross, Kristen R. Trexler, Kim Wix, Aubrie A. Harland, Thomas E. Prisinzano, Jeffrey Aubé, Steven G. Kinsey, Terry Kenakin, David P. Siderovski and Vincent Setola
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 487-499; DOI: https://doi.org/10.1124/jpet.118.255661
  5. He, Wenqi

    1. You have access
      The Role of Dopamine D3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens
      Mei Huang, Wenqi He, Béla Kiss, Bence Farkas, Nika Adham and Herbert Y. Meltzer
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 517-525; DOI: https://doi.org/10.1124/jpet.119.259879
  6. Holstein, Sarah A.

    1. You have access
      In Vivo Evaluation of Isoprenoid Triazole Bisphosphonate Inhibitors of Geranylgeranyl Diphosphate Synthase: Impact of Olefin Stereochemistry on Toxicity and Biodistribution
      Staci L. Haney, Yashpal S. Chhonker, Michelle L. Varney, Geoffrey Talmon, Lynette M. Smith, Daryl J. Murry and Sarah A. Holstein
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 327-338; DOI: https://doi.org/10.1124/jpet.119.258624
  7. Holub, Corine

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  8. Hong, Sa-Ik

    1. You have access
      Novel Adenosine Analog, N6-(4-Hydroxybenzyl)-Adenosine, Dampens Alcohol Drinking and Seeking Behaviors
      Sa-Ik Hong, Lee Peyton, Yijuang Chern and Doo-Sup Choi
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 260-267; DOI: https://doi.org/10.1124/jpet.119.261529
  9. Hu, Tongtong

    1. You have access
      Indigo Fruits Ingredient, Aucubin, Protects against LPS-Induced Cardiac Dysfunction in Mice
      MingXia Duan, Yuan Yuan, Chen Liu, Zhulan Cai, Qingwen Xie, Tongtong Hu, Qizhu Tang and QingQing Wu
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 348-359; DOI: https://doi.org/10.1124/jpet.119.259069
  10. Huang, Huey-Jing

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  11. Huang, Mei

    1. You have access
      The Role of Dopamine D3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens
      Mei Huang, Wenqi He, Béla Kiss, Bence Farkas, Nika Adham and Herbert Y. Meltzer
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 517-525; DOI: https://doi.org/10.1124/jpet.119.259879
  12. Huang Devine, Zheng

    1. You have access
      Pharmacological Profile of JNJ-64179375: A Novel, Long-Acting Exosite-1 Thrombin Inhibitor
      Zheng Huang Devine, Fuyong Du, Qiu Li, Matthew Bunce, Eilyn R. Lacy and Madhu Chintala
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 375-384; DOI: https://doi.org/10.1124/jpet.119.261032
  13. Huhn, Andrew S.

    1. You have access
      Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence
      Kelly E. Dunn, Andrew S. Huhn, Cecilia L. Bergeria, Cassandra D. Gipson and Elise M. Weerts
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 422-452; DOI: https://doi.org/10.1124/jpet.119.258004
  14. Husbands, Stephen M.

    1. You have access
      Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats
      Lisa R. Gerak, Vanessa Minervini, Elizabeth Latham, Saba Ghodrati, Katherine V. Lillis, Jessica Wooden, Alex Disney, Stephen M. Husbands and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 507-516; DOI: https://doi.org/10.1124/jpet.119.260331

I

  1. Ikeda, Shota

    1. You have access
      A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in ApoE Knockout Mice
      Shuichi Takagahara, Hiromi Shinohara, Shigekazu Itokawa, Yoshinori Satomi, Ayumi Ando, Takeshi Yamamoto, Hideo Suzuki, Takuya Fujimoto, Kazuki Kubo and Shota Ikeda
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 290-298; DOI: https://doi.org/10.1124/jpet.119.259846
  2. Itokawa, Shigekazu

    1. You have access
      A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in ApoE Knockout Mice
      Shuichi Takagahara, Hiromi Shinohara, Shigekazu Itokawa, Yoshinori Satomi, Ayumi Ando, Takeshi Yamamoto, Hideo Suzuki, Takuya Fujimoto, Kazuki Kubo and Shota Ikeda
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 290-298; DOI: https://doi.org/10.1124/jpet.119.259846

J

  1. Janganati, Venumadhav

    1. You have access
      GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine
      Na-Ra Lee, Guangrong Zheng, Markos Leggas, Venumadhav Janganati, Justin R. Nickell, Peter A. Crooks, Michael T. Bardo and Linda P. Dwoskin
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 526-543; DOI: https://doi.org/10.1124/jpet.119.258699
  2. Janowsky, Aaron

    1. You have access
      Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis
      Randy Torralva and Aaron Janowsky
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 453-475; DOI: https://doi.org/10.1124/jpet.119.258566
  3. Jonson, Samantha G.

    1. You have access
      The Opioid Crisis and the Future of Addiction and Pain Therapeutics
      Nathan P. Coussens, G. Sitta Sittampalam, Samantha G. Jonson, Matthew D. Hall, Heather E. Gorby, Amir P. Tamiz, Owen B. McManus, Christian C. Felder and Kurt Rasmussen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 396-408; DOI: https://doi.org/10.1124/jpet.119.259408

K

  1. Kaski, Shane W.

    1. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      You have access
      Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      Shane W. Kaski, Allison N. White, Joshua D. Gross, Kristen R. Trexler, Kim Wix, Aubrie A. Harland, Thomas E. Prisinzano, Jeffrey Aubé, Steven G. Kinsey, Terry Kenakin, David P. Siderovski and Vincent Setola
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 487-499; DOI: https://doi.org/10.1124/jpet.118.255661
  2. Kenakin, Terry

    1. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      You have access
      Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      Shane W. Kaski, Allison N. White, Joshua D. Gross, Kristen R. Trexler, Kim Wix, Aubrie A. Harland, Thomas E. Prisinzano, Jeffrey Aubé, Steven G. Kinsey, Terry Kenakin, David P. Siderovski and Vincent Setola
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 487-499; DOI: https://doi.org/10.1124/jpet.118.255661
  3. Kim, Donghwan

    1. You have access
      Withaferin A Improves Nonalcoholic Steatohepatitis in Mice
      Daxesh P. Patel, Tingting Yan, Donghwan Kim, Henrique B. Dias, Kristopher W. Krausz, Shioko Kimura and Frank J. Gonzalez
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 360-374; DOI: https://doi.org/10.1124/jpet.119.256792
  4. Kimura, Shioko

    1. You have access
      Withaferin A Improves Nonalcoholic Steatohepatitis in Mice
      Daxesh P. Patel, Tingting Yan, Donghwan Kim, Henrique B. Dias, Kristopher W. Krausz, Shioko Kimura and Frank J. Gonzalez
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 360-374; DOI: https://doi.org/10.1124/jpet.119.256792
  5. Kinsey, Steven G.

    1. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      You have access
      Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      Shane W. Kaski, Allison N. White, Joshua D. Gross, Kristen R. Trexler, Kim Wix, Aubrie A. Harland, Thomas E. Prisinzano, Jeffrey Aubé, Steven G. Kinsey, Terry Kenakin, David P. Siderovski and Vincent Setola
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 487-499; DOI: https://doi.org/10.1124/jpet.118.255661
  6. Kiss, Béla

    1. You have access
      The Role of Dopamine D3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens
      Mei Huang, Wenqi He, Béla Kiss, Bence Farkas, Nika Adham and Herbert Y. Meltzer
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 517-525; DOI: https://doi.org/10.1124/jpet.119.259879
  7. Klimberg, V. Suzanne

    1. You have access
      Doxorubicin Activates Ryanodine Receptors in Rat Lymphatic Muscle Cells to Attenuate Rhythmic Contractions and Lymph Flow
      Amanda J. Stolarz, Mustafa Sarimollaoglu, John C. Marecki, Terry W. Fletcher, Ekaterina I. Galanzha, Sung W. Rhee, Vladimir P. Zharov, V. Suzanne Klimberg and Nancy J. Rusch
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 278-289; DOI: https://doi.org/10.1124/jpet.119.257592
  8. Knutson, Charles G.

    1. You have access
      Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat
      James T. Meyer, Brian A. Sparling, William J. McCarty, Maosheng Zhang, Marcus Soto, Stephen Schneider, Hao Chen, Jonathan Roberts, Helming Tan, Thomas Kornecook, Paul S. Andrews and Charles G. Knutson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 476-486; DOI: https://doi.org/10.1124/jpet.119.257105
  9. Kornecook, Thomas

    1. You have access
      Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat
      James T. Meyer, Brian A. Sparling, William J. McCarty, Maosheng Zhang, Marcus Soto, Stephen Schneider, Hao Chen, Jonathan Roberts, Helming Tan, Thomas Kornecook, Paul S. Andrews and Charles G. Knutson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 476-486; DOI: https://doi.org/10.1124/jpet.119.257105
  10. Krausz, Kristopher W.

    1. You have access
      Withaferin A Improves Nonalcoholic Steatohepatitis in Mice
      Daxesh P. Patel, Tingting Yan, Donghwan Kim, Henrique B. Dias, Kristopher W. Krausz, Shioko Kimura and Frank J. Gonzalez
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 360-374; DOI: https://doi.org/10.1124/jpet.119.256792
  11. Krieter, Philip

    1. You have access
      Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose
      Philip Krieter, Shwe Gyaw, Roger Crystal and Phil Skolnick
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 409-415; DOI: https://doi.org/10.1124/jpet.118.256115
  12. Kubo, Kazuki

    1. You have access
      A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in ApoE Knockout Mice
      Shuichi Takagahara, Hiromi Shinohara, Shigekazu Itokawa, Yoshinori Satomi, Ayumi Ando, Takeshi Yamamoto, Hideo Suzuki, Takuya Fujimoto, Kazuki Kubo and Shota Ikeda
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 290-298; DOI: https://doi.org/10.1124/jpet.119.259846
  13. Kuo, Joseph

    1. Open Access
      A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
      Joseph Kuo, Michael Bobardt, Udayan Chatterji, Patrick R. Mayo, Daniel J. Trepanier, Robert T. Foster, Philippe Gallay and Daren R. Ure
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 231-241; DOI: https://doi.org/10.1124/jpet.119.261099

L

  1. Lacy, Eilyn R.

    1. You have access
      Pharmacological Profile of JNJ-64179375: A Novel, Long-Acting Exosite-1 Thrombin Inhibitor
      Zheng Huang Devine, Fuyong Du, Qiu Li, Matthew Bunce, Eilyn R. Lacy and Madhu Chintala
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 375-384; DOI: https://doi.org/10.1124/jpet.119.261032
  2. Larson, Christopher J.

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  3. Latham, Elizabeth

    1. You have access
      Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats
      Lisa R. Gerak, Vanessa Minervini, Elizabeth Latham, Saba Ghodrati, Katherine V. Lillis, Jessica Wooden, Alex Disney, Stephen M. Husbands and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 507-516; DOI: https://doi.org/10.1124/jpet.119.260331
  4. Lee, Na-Ra

    1. You have access
      GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine
      Na-Ra Lee, Guangrong Zheng, Markos Leggas, Venumadhav Janganati, Justin R. Nickell, Peter A. Crooks, Michael T. Bardo and Linda P. Dwoskin
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 526-543; DOI: https://doi.org/10.1124/jpet.119.258699
  5. Leggas, Markos

    1. You have access
      GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine
      Na-Ra Lee, Guangrong Zheng, Markos Leggas, Venumadhav Janganati, Justin R. Nickell, Peter A. Crooks, Michael T. Bardo and Linda P. Dwoskin
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 526-543; DOI: https://doi.org/10.1124/jpet.119.258699
  6. Le Gonidec, Sophie

    1. You have access
      Oral Phenelzine Treatment Mitigates Metabolic Disturbances in Mice Fed a High-Fat Diet
      Josep Mercader, Agustín G. Sabater, Sophie Le Gonidec, Pauline Decaunes, Alice Chaplin, Saioa Gómez-Zorita, Fermín I. Milagro and Christian Carpéné
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 555-566; DOI: https://doi.org/10.1124/jpet.119.259895
  7. Li, Qiu

    1. You have access
      Pharmacological Profile of JNJ-64179375: A Novel, Long-Acting Exosite-1 Thrombin Inhibitor
      Zheng Huang Devine, Fuyong Du, Qiu Li, Matthew Bunce, Eilyn R. Lacy and Madhu Chintala
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 375-384; DOI: https://doi.org/10.1124/jpet.119.261032
  8. Lillis, Katherine V.

    1. You have access
      Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats
      Lisa R. Gerak, Vanessa Minervini, Elizabeth Latham, Saba Ghodrati, Katherine V. Lillis, Jessica Wooden, Alex Disney, Stephen M. Husbands and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 507-516; DOI: https://doi.org/10.1124/jpet.119.260331
  9. Liu, Chen

    1. You have access
      Indigo Fruits Ingredient, Aucubin, Protects against LPS-Induced Cardiac Dysfunction in Mice
      MingXia Duan, Yuan Yuan, Chen Liu, Zhulan Cai, Qingwen Xie, Tongtong Hu, Qizhu Tang and QingQing Wu
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 348-359; DOI: https://doi.org/10.1124/jpet.119.259069
  10. Lucki, Irwin

    1. You have access
      Addressing the Opioid Crisis: Medical Student Instruction in Opioid Drug Pharmacology, Pain Management, and Substance Use Disorders
      Brian M. Cox, Thomas E. Cote and Irwin Lucki
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 500-506; DOI: https://doi.org/10.1124/jpet.119.257329
  11. Lynch, Katherine D.

    1. You have access
      A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model
      Michelle L. Montonye, Dan-Dan Tian, Tarana Arman, Katherine D. Lynch, Bruno Hagenbuch, Mary F. Paine and John D. Clarke
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 385-393; DOI: https://doi.org/10.1124/jpet.119.260489

M

  1. Marecki, John C.

    1. You have access
      Doxorubicin Activates Ryanodine Receptors in Rat Lymphatic Muscle Cells to Attenuate Rhythmic Contractions and Lymph Flow
      Amanda J. Stolarz, Mustafa Sarimollaoglu, John C. Marecki, Terry W. Fletcher, Ekaterina I. Galanzha, Sung W. Rhee, Vladimir P. Zharov, V. Suzanne Klimberg and Nancy J. Rusch
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 278-289; DOI: https://doi.org/10.1124/jpet.119.257592
  2. Marek, Gerard J.

    1. You have access
      Translating Pharmacology into Therapeutics to Fight the Opioid Crisis
      Gerard J. Marek, Kathryn A. Cunningham and Kurt Rasmussen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 394-395; DOI: https://doi.org/10.1124/jpet.119.262477
  3. Matuszkiewicz, Jennifer

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  4. Mayo, Patrick R.

    1. Open Access
      A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
      Joseph Kuo, Michael Bobardt, Udayan Chatterji, Patrick R. Mayo, Daniel J. Trepanier, Robert T. Foster, Philippe Gallay and Daren R. Ure
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 231-241; DOI: https://doi.org/10.1124/jpet.119.261099
  5. Mazur, Crystal

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  6. McBride, Christopher

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  7. McCarty, William J.

    1. You have access
      Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat
      James T. Meyer, Brian A. Sparling, William J. McCarty, Maosheng Zhang, Marcus Soto, Stephen Schneider, Hao Chen, Jonathan Roberts, Helming Tan, Thomas Kornecook, Paul S. Andrews and Charles G. Knutson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 476-486; DOI: https://doi.org/10.1124/jpet.119.257105
  8. McManus, Owen B.

    1. You have access
      The Opioid Crisis and the Future of Addiction and Pain Therapeutics
      Nathan P. Coussens, G. Sitta Sittampalam, Samantha G. Jonson, Matthew D. Hall, Heather E. Gorby, Amir P. Tamiz, Owen B. McManus, Christian C. Felder and Kurt Rasmussen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 396-408; DOI: https://doi.org/10.1124/jpet.119.259408
  9. Meltzer, Herbert Y.

    1. You have access
      The Role of Dopamine D3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens
      Mei Huang, Wenqi He, Béla Kiss, Bence Farkas, Nika Adham and Herbert Y. Meltzer
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 517-525; DOI: https://doi.org/10.1124/jpet.119.259879
  10. Mercader, Josep

    1. You have access
      Oral Phenelzine Treatment Mitigates Metabolic Disturbances in Mice Fed a High-Fat Diet
      Josep Mercader, Agustín G. Sabater, Sophie Le Gonidec, Pauline Decaunes, Alice Chaplin, Saioa Gómez-Zorita, Fermín I. Milagro and Christian Carpéné
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 555-566; DOI: https://doi.org/10.1124/jpet.119.259895
  11. Metzel, Lauren

    1. Open Access
      Age- and Sex-Specific Plasticity in Dopamine Transporter Function Revealed by Food Restriction and Exercise in a Rat Activity-Based Anorexia Paradigm
      T. Lee Gilman, W. Anthony Owens, Christina M. George, Lauren Metzel, Melissa Vitela, Livia Ferreira, Melodi A. Bowman, Georgianna G. Gould, Glenn M. Toney and Lynette C. Daws
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 268-277; DOI: https://doi.org/10.1124/jpet.119.260794
  12. Meyer, James T.

    1. You have access
      Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat
      James T. Meyer, Brian A. Sparling, William J. McCarty, Maosheng Zhang, Marcus Soto, Stephen Schneider, Hao Chen, Jonathan Roberts, Helming Tan, Thomas Kornecook, Paul S. Andrews and Charles G. Knutson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 476-486; DOI: https://doi.org/10.1124/jpet.119.257105
  13. Milagro, Fermín I.

    1. You have access
      Oral Phenelzine Treatment Mitigates Metabolic Disturbances in Mice Fed a High-Fat Diet
      Josep Mercader, Agustín G. Sabater, Sophie Le Gonidec, Pauline Decaunes, Alice Chaplin, Saioa Gómez-Zorita, Fermín I. Milagro and Christian Carpéné
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 555-566; DOI: https://doi.org/10.1124/jpet.119.259895
  14. Minervini, Vanessa

    1. You have access
      Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats
      Lisa R. Gerak, Vanessa Minervini, Elizabeth Latham, Saba Ghodrati, Katherine V. Lillis, Jessica Wooden, Alex Disney, Stephen M. Husbands and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 507-516; DOI: https://doi.org/10.1124/jpet.119.260331
  15. Montonye, Michelle L.

    1. You have access
      A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model
      Michelle L. Montonye, Dan-Dan Tian, Tarana Arman, Katherine D. Lynch, Bruno Hagenbuch, Mary F. Paine and John D. Clarke
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 385-393; DOI: https://doi.org/10.1124/jpet.119.260489
  16. Murry, Daryl J.

    1. You have access
      In Vivo Evaluation of Isoprenoid Triazole Bisphosphonate Inhibitors of Geranylgeranyl Diphosphate Synthase: Impact of Olefin Stereochemistry on Toxicity and Biodistribution
      Staci L. Haney, Yashpal S. Chhonker, Michelle L. Varney, Geoffrey Talmon, Lynette M. Smith, Daryl J. Murry and Sarah A. Holstein
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 327-338; DOI: https://doi.org/10.1124/jpet.119.258624

N

  1. Nickell, Justin R.

    1. You have access
      GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine
      Na-Ra Lee, Guangrong Zheng, Markos Leggas, Venumadhav Janganati, Justin R. Nickell, Peter A. Crooks, Michael T. Bardo and Linda P. Dwoskin
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 526-543; DOI: https://doi.org/10.1124/jpet.119.258699
  2. Niesters, Marieke

    1. You have access
      A Pragmatic Utility Function to Describe the Risk-Benefit Composite of Opioid and Nonopioid Analgesic Medication
      Anne E. Olesen, Suzanne Broens, Søren S. Olesen, Marieke Niesters, Monique van Velzen, Asbjørn M. Drewes, Albert Dahan and Erik Olofsen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 416-421; DOI: https://doi.org/10.1124/jpet.118.253716

O

  1. O’Donnell, James M.

    1. Open Access
      Protection from Amyloid β Peptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor
      Su-Ying Cui, Ming-Xin Yang, Yong-He Zhang, Victor Zheng, Han-Ting Zhang, Mark E. Gurney, Ying Xu and James M. O’Donnell
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 250-259; DOI: https://doi.org/10.1124/jpet.119.259986
  2. Olesen, Anne E.

    1. You have access
      A Pragmatic Utility Function to Describe the Risk-Benefit Composite of Opioid and Nonopioid Analgesic Medication
      Anne E. Olesen, Suzanne Broens, Søren S. Olesen, Marieke Niesters, Monique van Velzen, Asbjørn M. Drewes, Albert Dahan and Erik Olofsen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 416-421; DOI: https://doi.org/10.1124/jpet.118.253716
  3. Olesen, Søren S.

    1. You have access
      A Pragmatic Utility Function to Describe the Risk-Benefit Composite of Opioid and Nonopioid Analgesic Medication
      Anne E. Olesen, Suzanne Broens, Søren S. Olesen, Marieke Niesters, Monique van Velzen, Asbjørn M. Drewes, Albert Dahan and Erik Olofsen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 416-421; DOI: https://doi.org/10.1124/jpet.118.253716
  4. Olofsen, Erik

    1. You have access
      A Pragmatic Utility Function to Describe the Risk-Benefit Composite of Opioid and Nonopioid Analgesic Medication
      Anne E. Olesen, Suzanne Broens, Søren S. Olesen, Marieke Niesters, Monique van Velzen, Asbjørn M. Drewes, Albert Dahan and Erik Olofsen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 416-421; DOI: https://doi.org/10.1124/jpet.118.253716
  5. Owens, W. Anthony

    1. Open Access
      Age- and Sex-Specific Plasticity in Dopamine Transporter Function Revealed by Food Restriction and Exercise in a Rat Activity-Based Anorexia Paradigm
      T. Lee Gilman, W. Anthony Owens, Christina M. George, Lauren Metzel, Melissa Vitela, Livia Ferreira, Melodi A. Bowman, Georgianna G. Gould, Glenn M. Toney and Lynette C. Daws
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 268-277; DOI: https://doi.org/10.1124/jpet.119.260794

P

  1. Pachori, Alok

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  2. Paine, Mary F.

    1. You have access
      A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model
      Michelle L. Montonye, Dan-Dan Tian, Tarana Arman, Katherine D. Lynch, Bruno Hagenbuch, Mary F. Paine and John D. Clarke
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 385-393; DOI: https://doi.org/10.1124/jpet.119.260489
  3. Pan, Hui-Lin

    1. You have access
      Streptozotocin-Induced Diabetic Neuropathic Pain Is Associated with Potentiated Calcium-Permeable AMPA Receptor Activity in the Spinal Cord
      Shao-Rui Chen, Jixiang Zhang, Hong Chen and Hui-Lin Pan
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 242-249; DOI: https://doi.org/10.1124/jpet.119.261339
  4. Paronis, Carol A.

    1. You have access
      Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment
      Sarah L. Withey, Roger D. Spealman, Jack Bergman and Carol A. Paronis
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 544-554; DOI: https://doi.org/10.1124/jpet.119.259010
  5. Patel, Daxesh P.

    1. You have access
      Withaferin A Improves Nonalcoholic Steatohepatitis in Mice
      Daxesh P. Patel, Tingting Yan, Donghwan Kim, Henrique B. Dias, Kristopher W. Krausz, Shioko Kimura and Frank J. Gonzalez
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 360-374; DOI: https://doi.org/10.1124/jpet.119.256792
  6. Peyton, Lee

    1. You have access
      Novel Adenosine Analog, N6-(4-Hydroxybenzyl)-Adenosine, Dampens Alcohol Drinking and Seeking Behaviors
      Sa-Ik Hong, Lee Peyton, Yijuang Chern and Doo-Sup Choi
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 260-267; DOI: https://doi.org/10.1124/jpet.119.261529
  7. Plonowski, Artur

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  8. Prisinzano, Thomas E.

    1. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      You have access
      Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      Shane W. Kaski, Allison N. White, Joshua D. Gross, Kristen R. Trexler, Kim Wix, Aubrie A. Harland, Thomas E. Prisinzano, Jeffrey Aubé, Steven G. Kinsey, Terry Kenakin, David P. Siderovski and Vincent Setola
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 487-499; DOI: https://doi.org/10.1124/jpet.118.255661
  9. Pulaski, Lukasz

    1. You have access
      Direct Measurement of Kinetic Parameters of ABCG2-Dependent Transport of Natural Flavonoids Using a Fluorogenic Substrate
      Michal Rozanski, Maciej Studzian and Lukasz Pulaski
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 309-319; DOI: https://doi.org/10.1124/jpet.119.261347

R

  1. Rasmussen, Kurt

    1. You have access
      Translating Pharmacology into Therapeutics to Fight the Opioid Crisis
      Gerard J. Marek, Kathryn A. Cunningham and Kurt Rasmussen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 394-395; DOI: https://doi.org/10.1124/jpet.119.262477
    2. You have access
      The Opioid Crisis and the Future of Addiction and Pain Therapeutics
      Nathan P. Coussens, G. Sitta Sittampalam, Samantha G. Jonson, Matthew D. Hall, Heather E. Gorby, Amir P. Tamiz, Owen B. McManus, Christian C. Felder and Kurt Rasmussen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 396-408; DOI: https://doi.org/10.1124/jpet.119.259408
  2. Rhee, Sung W.

    1. You have access
      Doxorubicin Activates Ryanodine Receptors in Rat Lymphatic Muscle Cells to Attenuate Rhythmic Contractions and Lymph Flow
      Amanda J. Stolarz, Mustafa Sarimollaoglu, John C. Marecki, Terry W. Fletcher, Ekaterina I. Galanzha, Sung W. Rhee, Vladimir P. Zharov, V. Suzanne Klimberg and Nancy J. Rusch
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 278-289; DOI: https://doi.org/10.1124/jpet.119.257592
  3. Roberts, Jonathan

    1. You have access
      Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat
      James T. Meyer, Brian A. Sparling, William J. McCarty, Maosheng Zhang, Marcus Soto, Stephen Schneider, Hao Chen, Jonathan Roberts, Helming Tan, Thomas Kornecook, Paul S. Andrews and Charles G. Knutson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 476-486; DOI: https://doi.org/10.1124/jpet.119.257105
  4. Rolzin, Paul

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
  5. Rozanski, Michal

    1. You have access
      Direct Measurement of Kinetic Parameters of ABCG2-Dependent Transport of Natural Flavonoids Using a Fluorogenic Substrate
      Michal Rozanski, Maciej Studzian and Lukasz Pulaski
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 309-319; DOI: https://doi.org/10.1124/jpet.119.261347
  6. Rusch, Nancy J.

    1. You have access
      Doxorubicin Activates Ryanodine Receptors in Rat Lymphatic Muscle Cells to Attenuate Rhythmic Contractions and Lymph Flow
      Amanda J. Stolarz, Mustafa Sarimollaoglu, John C. Marecki, Terry W. Fletcher, Ekaterina I. Galanzha, Sung W. Rhee, Vladimir P. Zharov, V. Suzanne Klimberg and Nancy J. Rusch
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 278-289; DOI: https://doi.org/10.1124/jpet.119.257592

S

  1. Sabater, Agustín G.

    1. You have access
      Oral Phenelzine Treatment Mitigates Metabolic Disturbances in Mice Fed a High-Fat Diet
      Josep Mercader, Agustín G. Sabater, Sophie Le Gonidec, Pauline Decaunes, Alice Chaplin, Saioa Gómez-Zorita, Fermín I. Milagro and Christian Carpéné
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 555-566; DOI: https://doi.org/10.1124/jpet.119.259895
  2. Sarimollaoglu, Mustafa

    1. You have access
      Doxorubicin Activates Ryanodine Receptors in Rat Lymphatic Muscle Cells to Attenuate Rhythmic Contractions and Lymph Flow
      Amanda J. Stolarz, Mustafa Sarimollaoglu, John C. Marecki, Terry W. Fletcher, Ekaterina I. Galanzha, Sung W. Rhee, Vladimir P. Zharov, V. Suzanne Klimberg and Nancy J. Rusch
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 278-289; DOI: https://doi.org/10.1124/jpet.119.257592
  3. Satomi, Yoshinori

    1. You have access
      A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in ApoE Knockout Mice
      Shuichi Takagahara, Hiromi Shinohara, Shigekazu Itokawa, Yoshinori Satomi, Ayumi Ando, Takeshi Yamamoto, Hideo Suzuki, Takuya Fujimoto, Kazuki Kubo and Shota Ikeda
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 290-298; DOI: https://doi.org/10.1124/jpet.119.259846
  4. Schneider, Stephen

    1. You have access
      Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat
      James T. Meyer, Brian A. Sparling, William J. McCarty, Maosheng Zhang, Marcus Soto, Stephen Schneider, Hao Chen, Jonathan Roberts, Helming Tan, Thomas Kornecook, Paul S. Andrews and Charles G. Knutson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 476-486; DOI: https://doi.org/10.1124/jpet.119.257105
  5. Setola, Vincent

    1. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      You have access
      Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      Shane W. Kaski, Allison N. White, Joshua D. Gross, Kristen R. Trexler, Kim Wix, Aubrie A. Harland, Thomas E. Prisinzano, Jeffrey Aubé, Steven G. Kinsey, Terry Kenakin, David P. Siderovski and Vincent Setola
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 487-499; DOI: https://doi.org/10.1124/jpet.118.255661
  6. Shi, Xiangdang

    1. You have access
      Differential Roles of Accumbal GSK3β in Cocaine versus Morphine-Induced Place Preference, U50,488H-Induced Place Aversion, and Object Memory
      Xiangdang Shi, Jeffrey L. Barr, Eva von Weltin, Cassandra Wolsh and Ellen M. Unterwald
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 339-347; DOI: https://doi.org/10.1124/jpet.119.259283
  7. Shinohara, Hiromi

    1. You have access
      A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in ApoE Knockout Mice
      Shuichi Takagahara, Hiromi Shinohara, Shigekazu Itokawa, Yoshinori Satomi, Ayumi Ando, Takeshi Yamamoto, Hideo Suzuki, Takuya Fujimoto, Kazuki Kubo and Shota Ikeda
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 290-298; DOI: https://doi.org/10.1124/jpet.119.259846
  8. Siderovski, David P.

    1. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      You have access
      Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      Shane W. Kaski, Allison N. White, Joshua D. Gross, Kristen R. Trexler, Kim Wix, Aubrie A. Harland, Thomas E. Prisinzano, Jeffrey Aubé, Steven G. Kinsey, Terry Kenakin, David P. Siderovski and Vincent Setola
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 487-499; DOI: https://doi.org/10.1124/jpet.118.255661
  9. Sittampalam, G. Sitta

    1. You have access
      The Opioid Crisis and the Future of Addiction and Pain Therapeutics
      Nathan P. Coussens, G. Sitta Sittampalam, Samantha G. Jonson, Matthew D. Hall, Heather E. Gorby, Amir P. Tamiz, Owen B. McManus, Christian C. Felder and Kurt Rasmussen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 396-408; DOI: https://doi.org/10.1124/jpet.119.259408
  10. Skolnick, Phil

    1. You have access
      Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose
      Philip Krieter, Shwe Gyaw, Roger Crystal and Phil Skolnick
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 409-415; DOI: https://doi.org/10.1124/jpet.118.256115
  11. Smith, Lynette M.

    1. You have access
      In Vivo Evaluation of Isoprenoid Triazole Bisphosphonate Inhibitors of Geranylgeranyl Diphosphate Synthase: Impact of Olefin Stereochemistry on Toxicity and Biodistribution
      Staci L. Haney, Yashpal S. Chhonker, Michelle L. Varney, Geoffrey Talmon, Lynette M. Smith, Daryl J. Murry and Sarah A. Holstein
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 327-338; DOI: https://doi.org/10.1124/jpet.119.258624
  12. Soto, Marcus

    1. You have access
      Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat
      James T. Meyer, Brian A. Sparling, William J. McCarty, Maosheng Zhang, Marcus Soto, Stephen Schneider, Hao Chen, Jonathan Roberts, Helming Tan, Thomas Kornecook, Paul S. Andrews and Charles G. Knutson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 476-486; DOI: https://doi.org/10.1124/jpet.119.257105
  13. Sparling, Brian A.

    1. You have access
      Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat
      James T. Meyer, Brian A. Sparling, William J. McCarty, Maosheng Zhang, Marcus Soto, Stephen Schneider, Hao Chen, Jonathan Roberts, Helming Tan, Thomas Kornecook, Paul S. Andrews and Charles G. Knutson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 476-486; DOI: https://doi.org/10.1124/jpet.119.257105
  14. Spealman, Roger D.

    1. You have access
      Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment
      Sarah L. Withey, Roger D. Spealman, Jack Bergman and Carol A. Paronis
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 544-554; DOI: https://doi.org/10.1124/jpet.119.259010
  15. Stolarz, Amanda J.

    1. You have access
      Doxorubicin Activates Ryanodine Receptors in Rat Lymphatic Muscle Cells to Attenuate Rhythmic Contractions and Lymph Flow
      Amanda J. Stolarz, Mustafa Sarimollaoglu, John C. Marecki, Terry W. Fletcher, Ekaterina I. Galanzha, Sung W. Rhee, Vladimir P. Zharov, V. Suzanne Klimberg and Nancy J. Rusch
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 278-289; DOI: https://doi.org/10.1124/jpet.119.257592
  16. Studzian, Maciej

    1. You have access
      Direct Measurement of Kinetic Parameters of ABCG2-Dependent Transport of Natural Flavonoids Using a Fluorogenic Substrate
      Michal Rozanski, Maciej Studzian and Lukasz Pulaski
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 309-319; DOI: https://doi.org/10.1124/jpet.119.261347
  17. Suzuki, Hideo

    1. You have access
      A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in ApoE Knockout Mice
      Shuichi Takagahara, Hiromi Shinohara, Shigekazu Itokawa, Yoshinori Satomi, Ayumi Ando, Takeshi Yamamoto, Hideo Suzuki, Takuya Fujimoto, Kazuki Kubo and Shota Ikeda
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 290-298; DOI: https://doi.org/10.1124/jpet.119.259846

T

  1. Takagahara, Shuichi

    1. You have access
      A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in ApoE Knockout Mice
      Shuichi Takagahara, Hiromi Shinohara, Shigekazu Itokawa, Yoshinori Satomi, Ayumi Ando, Takeshi Yamamoto, Hideo Suzuki, Takuya Fujimoto, Kazuki Kubo and Shota Ikeda
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 290-298; DOI: https://doi.org/10.1124/jpet.119.259846
  2. Talmon, Geoffrey

    1. You have access
      In Vivo Evaluation of Isoprenoid Triazole Bisphosphonate Inhibitors of Geranylgeranyl Diphosphate Synthase: Impact of Olefin Stereochemistry on Toxicity and Biodistribution
      Staci L. Haney, Yashpal S. Chhonker, Michelle L. Varney, Geoffrey Talmon, Lynette M. Smith, Daryl J. Murry and Sarah A. Holstein
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 327-338; DOI: https://doi.org/10.1124/jpet.119.258624
  3. Tamiz, Amir P.

    1. You have access
      The Opioid Crisis and the Future of Addiction and Pain Therapeutics
      Nathan P. Coussens, G. Sitta Sittampalam, Samantha G. Jonson, Matthew D. Hall, Heather E. Gorby, Amir P. Tamiz, Owen B. McManus, Christian C. Felder and Kurt Rasmussen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 396-408; DOI: https://doi.org/10.1124/jpet.119.259408
  4. Tan, Helming

    1. You have access
      Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat
      James T. Meyer, Brian A. Sparling, William J. McCarty, Maosheng Zhang, Marcus Soto, Stephen Schneider, Hao Chen, Jonathan Roberts, Helming Tan, Thomas Kornecook, Paul S. Andrews and Charles G. Knutson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 476-486; DOI: https://doi.org/10.1124/jpet.119.257105
  5. Tang, Qizhu

    1. You have access
      Indigo Fruits Ingredient, Aucubin, Protects against LPS-Induced Cardiac Dysfunction in Mice
      MingXia Duan, Yuan Yuan, Chen Liu, Zhulan Cai, Qingwen Xie, Tongtong Hu, Qizhu Tang and QingQing Wu
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 348-359; DOI: https://doi.org/10.1124/jpet.119.259069
  6. Tian, Dan-Dan

    1. You have access
      A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model
      Michelle L. Montonye, Dan-Dan Tian, Tarana Arman, Katherine D. Lynch, Bruno Hagenbuch, Mary F. Paine and John D. Clarke
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 385-393; DOI: https://doi.org/10.1124/jpet.119.260489
  7. Toney, Glenn M.

    1. Open Access
      Age- and Sex-Specific Plasticity in Dopamine Transporter Function Revealed by Food Restriction and Exercise in a Rat Activity-Based Anorexia Paradigm
      T. Lee Gilman, W. Anthony Owens, Christina M. George, Lauren Metzel, Melissa Vitela, Livia Ferreira, Melodi A. Bowman, Georgianna G. Gould, Glenn M. Toney and Lynette C. Daws
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 268-277; DOI: https://doi.org/10.1124/jpet.119.260794
  8. Torralva, Randy

    1. You have access
      Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis
      Randy Torralva and Aaron Janowsky
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 453-475; DOI: https://doi.org/10.1124/jpet.119.258566
  9. Trepanier, Daniel J.

    1. Open Access
      A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
      Joseph Kuo, Michael Bobardt, Udayan Chatterji, Patrick R. Mayo, Daniel J. Trepanier, Robert T. Foster, Philippe Gallay and Daren R. Ure
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 231-241; DOI: https://doi.org/10.1124/jpet.119.261099
  10. Trexler, Kristen R.

    1. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      You have access
      Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      Shane W. Kaski, Allison N. White, Joshua D. Gross, Kristen R. Trexler, Kim Wix, Aubrie A. Harland, Thomas E. Prisinzano, Jeffrey Aubé, Steven G. Kinsey, Terry Kenakin, David P. Siderovski and Vincent Setola
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 487-499; DOI: https://doi.org/10.1124/jpet.118.255661

U

  1. Unterwald, Ellen M.

    1. You have access
      Differential Roles of Accumbal GSK3β in Cocaine versus Morphine-Induced Place Preference, U50,488H-Induced Place Aversion, and Object Memory
      Xiangdang Shi, Jeffrey L. Barr, Eva von Weltin, Cassandra Wolsh and Ellen M. Unterwald
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 339-347; DOI: https://doi.org/10.1124/jpet.119.259283
  2. Ure, Daren R.

    1. Open Access
      A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
      Joseph Kuo, Michael Bobardt, Udayan Chatterji, Patrick R. Mayo, Daniel J. Trepanier, Robert T. Foster, Philippe Gallay and Daren R. Ure
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 231-241; DOI: https://doi.org/10.1124/jpet.119.261099

V

  1. van Velzen, Monique

    1. You have access
      A Pragmatic Utility Function to Describe the Risk-Benefit Composite of Opioid and Nonopioid Analgesic Medication
      Anne E. Olesen, Suzanne Broens, Søren S. Olesen, Marieke Niesters, Monique van Velzen, Asbjørn M. Drewes, Albert Dahan and Erik Olofsen
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 416-421; DOI: https://doi.org/10.1124/jpet.118.253716
  2. Varney, Michelle L.

    1. You have access
      In Vivo Evaluation of Isoprenoid Triazole Bisphosphonate Inhibitors of Geranylgeranyl Diphosphate Synthase: Impact of Olefin Stereochemistry on Toxicity and Biodistribution
      Staci L. Haney, Yashpal S. Chhonker, Michelle L. Varney, Geoffrey Talmon, Lynette M. Smith, Daryl J. Murry and Sarah A. Holstein
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 327-338; DOI: https://doi.org/10.1124/jpet.119.258624
  3. Vitela, Melissa

    1. Open Access
      Age- and Sex-Specific Plasticity in Dopamine Transporter Function Revealed by Food Restriction and Exercise in a Rat Activity-Based Anorexia Paradigm
      T. Lee Gilman, W. Anthony Owens, Christina M. George, Lauren Metzel, Melissa Vitela, Livia Ferreira, Melodi A. Bowman, Georgianna G. Gould, Glenn M. Toney and Lynette C. Daws
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 268-277; DOI: https://doi.org/10.1124/jpet.119.260794
  4. von Weltin, Eva

    1. You have access
      Differential Roles of Accumbal GSK3β in Cocaine versus Morphine-Induced Place Preference, U50,488H-Induced Place Aversion, and Object Memory
      Xiangdang Shi, Jeffrey L. Barr, Eva von Weltin, Cassandra Wolsh and Ellen M. Unterwald
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 339-347; DOI: https://doi.org/10.1124/jpet.119.259283

W

  1. Weerts, Elise M.

    1. You have access
      Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence
      Kelly E. Dunn, Andrew S. Huhn, Cecilia L. Bergeria, Cassandra D. Gipson and Elise M. Weerts
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 422-452; DOI: https://doi.org/10.1124/jpet.119.258004
  2. White, Allison N.

    1. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      You have access
      Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      Shane W. Kaski, Allison N. White, Joshua D. Gross, Kristen R. Trexler, Kim Wix, Aubrie A. Harland, Thomas E. Prisinzano, Jeffrey Aubé, Steven G. Kinsey, Terry Kenakin, David P. Siderovski and Vincent Setola
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 487-499; DOI: https://doi.org/10.1124/jpet.118.255661
  3. Withey, Sarah L.

    1. You have access
      Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment
      Sarah L. Withey, Roger D. Spealman, Jack Bergman and Carol A. Paronis
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 544-554; DOI: https://doi.org/10.1124/jpet.119.259010
  4. Wix, Kim

    1. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      You have access
      Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
      Shane W. Kaski, Allison N. White, Joshua D. Gross, Kristen R. Trexler, Kim Wix, Aubrie A. Harland, Thomas E. Prisinzano, Jeffrey Aubé, Steven G. Kinsey, Terry Kenakin, David P. Siderovski and Vincent Setola
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 487-499; DOI: https://doi.org/10.1124/jpet.118.255661
  5. Wolsh, Cassandra

    1. You have access
      Differential Roles of Accumbal GSK3β in Cocaine versus Morphine-Induced Place Preference, U50,488H-Induced Place Aversion, and Object Memory
      Xiangdang Shi, Jeffrey L. Barr, Eva von Weltin, Cassandra Wolsh and Ellen M. Unterwald
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 339-347; DOI: https://doi.org/10.1124/jpet.119.259283
  6. Wooden, Jessica

    1. You have access
      Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats
      Lisa R. Gerak, Vanessa Minervini, Elizabeth Latham, Saba Ghodrati, Katherine V. Lillis, Jessica Wooden, Alex Disney, Stephen M. Husbands and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 507-516; DOI: https://doi.org/10.1124/jpet.119.260331
  7. Wu, QingQing

    1. You have access
      Indigo Fruits Ingredient, Aucubin, Protects against LPS-Induced Cardiac Dysfunction in Mice
      MingXia Duan, Yuan Yuan, Chen Liu, Zhulan Cai, Qingwen Xie, Tongtong Hu, Qizhu Tang and QingQing Wu
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 348-359; DOI: https://doi.org/10.1124/jpet.119.259069

X

  1. Xie, Qingwen

    1. You have access
      Indigo Fruits Ingredient, Aucubin, Protects against LPS-Induced Cardiac Dysfunction in Mice
      MingXia Duan, Yuan Yuan, Chen Liu, Zhulan Cai, Qingwen Xie, Tongtong Hu, Qizhu Tang and QingQing Wu
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 348-359; DOI: https://doi.org/10.1124/jpet.119.259069
  2. Xu, Ying

    1. Open Access
      Protection from Amyloid β Peptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor
      Su-Ying Cui, Ming-Xin Yang, Yong-He Zhang, Victor Zheng, Han-Ting Zhang, Mark E. Gurney, Ying Xu and James M. O’Donnell
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 250-259; DOI: https://doi.org/10.1124/jpet.119.259986

Y

  1. Yamamoto, Takeshi

    1. You have access
      A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in ApoE Knockout Mice
      Shuichi Takagahara, Hiromi Shinohara, Shigekazu Itokawa, Yoshinori Satomi, Ayumi Ando, Takeshi Yamamoto, Hideo Suzuki, Takuya Fujimoto, Kazuki Kubo and Shota Ikeda
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 290-298; DOI: https://doi.org/10.1124/jpet.119.259846
  2. Yan, Tingting

    1. You have access
      Withaferin A Improves Nonalcoholic Steatohepatitis in Mice
      Daxesh P. Patel, Tingting Yan, Donghwan Kim, Henrique B. Dias, Kristopher W. Krausz, Shioko Kimura and Frank J. Gonzalez
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 360-374; DOI: https://doi.org/10.1124/jpet.119.256792
  3. Yang, Ming-Xin

    1. Open Access
      Protection from Amyloid β Peptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor
      Su-Ying Cui, Ming-Xin Yang, Yong-He Zhang, Victor Zheng, Han-Ting Zhang, Mark E. Gurney, Ying Xu and James M. O’Donnell
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 250-259; DOI: https://doi.org/10.1124/jpet.119.259986
  4. Yuan, Yuan

    1. You have access
      Indigo Fruits Ingredient, Aucubin, Protects against LPS-Induced Cardiac Dysfunction in Mice
      MingXia Duan, Yuan Yuan, Chen Liu, Zhulan Cai, Qingwen Xie, Tongtong Hu, Qizhu Tang and QingQing Wu
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 348-359; DOI: https://doi.org/10.1124/jpet.119.259069

Z

  1. Zhang, Han-Ting

    1. Open Access
      Protection from Amyloid β Peptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor
      Su-Ying Cui, Ming-Xin Yang, Yong-He Zhang, Victor Zheng, Han-Ting Zhang, Mark E. Gurney, Ying Xu and James M. O’Donnell
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 250-259; DOI: https://doi.org/10.1124/jpet.119.259986
  2. Zhang, Jian-Ting

    1. You have access
      CC-115, a Dual Mammalian Target of Rapamycin/DNA-Dependent Protein Kinase Inhibitor in Clinical Trial, Is a Substrate of ATP-Binding Cassette G2, a Risk Factor for CC-115 Resistance
      Jenny Beebe and Jian-Ting Zhang
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 320-326; DOI: https://doi.org/10.1124/jpet.119.258392
  3. Zhang, Jixiang

    1. You have access
      Streptozotocin-Induced Diabetic Neuropathic Pain Is Associated with Potentiated Calcium-Permeable AMPA Receptor Activity in the Spinal Cord
      Shao-Rui Chen, Jixiang Zhang, Hong Chen and Hui-Lin Pan
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 242-249; DOI: https://doi.org/10.1124/jpet.119.261339
  4. Zhang, Maosheng

    1. You have access
      Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat
      James T. Meyer, Brian A. Sparling, William J. McCarty, Maosheng Zhang, Marcus Soto, Stephen Schneider, Hao Chen, Jonathan Roberts, Helming Tan, Thomas Kornecook, Paul S. Andrews and Charles G. Knutson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 476-486; DOI: https://doi.org/10.1124/jpet.119.257105
  5. Zhang, Yong-He

    1. Open Access
      Protection from Amyloid β Peptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor
      Su-Ying Cui, Ming-Xin Yang, Yong-He Zhang, Victor Zheng, Han-Ting Zhang, Mark E. Gurney, Ying Xu and James M. O’Donnell
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 250-259; DOI: https://doi.org/10.1124/jpet.119.259986
  6. Zharov, Vladimir P.

    1. You have access
      Doxorubicin Activates Ryanodine Receptors in Rat Lymphatic Muscle Cells to Attenuate Rhythmic Contractions and Lymph Flow
      Amanda J. Stolarz, Mustafa Sarimollaoglu, John C. Marecki, Terry W. Fletcher, Ekaterina I. Galanzha, Sung W. Rhee, Vladimir P. Zharov, V. Suzanne Klimberg and Nancy J. Rusch
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 278-289; DOI: https://doi.org/10.1124/jpet.119.257592
  7. Zheng, Guangrong

    1. You have access
      GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine
      Na-Ra Lee, Guangrong Zheng, Markos Leggas, Venumadhav Janganati, Justin R. Nickell, Peter A. Crooks, Michael T. Bardo and Linda P. Dwoskin
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 526-543; DOI: https://doi.org/10.1124/jpet.119.258699
  8. Zheng, Victor

    1. Open Access
      Protection from Amyloid β Peptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor
      Su-Ying Cui, Ming-Xin Yang, Yong-He Zhang, Victor Zheng, Han-Ting Zhang, Mark E. Gurney, Ying Xu and James M. O’Donnell
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 250-259; DOI: https://doi.org/10.1124/jpet.119.259986
  9. Zopf, Christopher J.

    1. You have access
      Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
      Pamela J. Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Plonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher McBride, Darian Bartkowski, Crystal Mazur, Alok Pachori and Christopher J. Larson
      Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 299-308; DOI: https://doi.org/10.1124/jpet.119.259028
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 371 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 371, Issue 2
1 Nov 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics